The PLA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with peripheral arterial disease.

نویسندگان

  • W Renner
  • M Brodmann
  • M Winkler
  • T C Washer
  • E Pilger
چکیده

mä~íÉäÉí ãÉãÄê~åÉ ÖäóÅçéêçíÉáå EdmF ffÄLfff~I ~ êÉÅÉéíçê Ñçê ÑáÄêáåJ çÖÉå ~åÇ îçå táääÉÄê~åÇ Ñ~ÅíçêI éä~óë ~ ã~àçê êçäÉ áå éä~íÉäÉí ÑìåÅíáçåK qÜÉ dm fff~ ëìÄìåáí Éñáëíë áå íïç éçäóãçêéÜáÅ î~êá~åíëI mä^N ~åÇ mä^OK qÜÉ ãçäÉÅìä~ê Ä~ëáë Ñçê íÜáë áë ~ ` q éçäóãçêéÜáëã ~í éçëáíáçå NRSR áå Éñçå O çÑ íÜÉ ÖÉåÉ Ñçê dm fff~I êÉëìäíáåÖ áå ~ äÉìÅáåÉ éêçäáåÉ ÉñÅÜ~åÖÉ ~í ~ãáåç ~ÅáÇ éçëáíáçå PP çÑ íÜÉ ã~íìêÉ éêçíÉáå ENFK `çåÑäáÅíáåÖ Ç~í~ ~Äçìí íÜÉ ÑìåÅíáçå~ä ÅçåëÉèìÉåÅÉë çÑ íÜÉ dm fff~ mä^NL^O éçäóãçêéÜáëã Ü~îÉ ÄÉÉå êÉéçêíÉÇK dççÇ~ää Éí ~äK Ü~îÉ äáåâÉÇ íÜÉ dm fff~ ÖÉåçíóéÉ íç ÄáåÇáåÖ çÑ ÑáÄêáåçÖÉå EOFI ïÜÉêÉ~ë çíÜÉê ëíìÇáÉë ÑçìåÇ åç ëìÅÜ ~ëëçÅá~íáçå EPI QFK qïç êÉÅÉåí ëíìÇáÉë êÉéçêíÉÇ ~Åíáî~íáçå çÑ mä^O éä~íÉäÉíë ~í äçïÉê ÇçëÉë çÑ éä~íÉäÉí ~Öçåáëíë ÉéáåÉéÜêáåÉ ERF ~åÇ ~ÇÉåçëáåÉ ÇáéÜçëéÜ~íÉ ESFI ïÜáäÉ i~ëåÉ Éí ~äK êÉéçêíÉÇ íÜ~í mä^O éä~íÉJ äÉíë êÉèìáêÉÇ ÜáÖÜÉê ÇçëÉë çÑ éä~íÉäÉí ~Öçåáëí íÜêçãÄáå êÉÅÉéíçê ~Åíáî~íJ áåÖ éÉéíáÇÉ Ñçê ~Åíáî~íáçå ETFK qÜÉ mä^O î~êá~åí Ü~ë ÑìêíÜÉêãçêÉ ÄÉÉå ~ëëçÅá~íÉÇ ïáíÜ áåÅêÉ~ëÉÇ ÉÑÑáÅ~Åó çÑ ~ëéáêáåÉ EUFK tÜáäÉ ëÉîÉê~ä ëíìÇáÉë Ü~îÉ äáåâÉÇ íÜáë ÖÉåÉíáÅ ã~êâÉê íç Å~êÇáçî~ëÅìä~ê ÇáëÉ~ëÉI ÉîÉå ãçêÉ ëíìÇáÉë Ñ~áäÉÇ íç ÇÉíÉÅí ëìÅÜ ~å ~ëëçÅá~íáçå xÑçê ëÜçêí çîÉêîáÉïI ëÉÉ _óJ òçî~ Éí ~äK EVFzK `ìêêÉåíäó åç ÅçåÅäìëáçå Å~å ÄÉ ã~ÇÉ ~Äçìí íÜÉ ÅäáåáÅ~ä êÉäÉî~åÅó çÑ íÜáë éçäóãçêéÜáëã Ñçê Å~êÇáçî~ëÅìä~ê ÇáëÉ~ëÉK eÉêÉ ïÉ éêÉëÉåí Ç~í~ çÑ ~ Å~ëÉJÅçåíêçä ëíìÇó ~Äçìí íÜÉ êçäÉ çÑ íÜÉ dm fff~ mä^NL^O éçäóãçêéÜáëã Ñçê éÉêáéÜÉê~ä ~êíÉêá~ä ÇáëÉ~ëÉ Em^aFK _ÉíïÉÉå aÉÅÉãÄÉê NVVT ~åÇ gìåÉ OMMMI UNR é~íáÉåíë ïáíÜ ÇçÅìJ ãÉåíÉÇ m^a ïÉêÉ êÉÅêìáíÉÇ ~í íÜÉ aáîáëáçå çÑ ^åÖáçäçÖóI aÉé~êíãÉåí çÑ fåíÉêå~ä jÉÇáÅáåÉI råáîÉêëáí®íëâäáåáâìã dê~òI ^ìëíêá~K ^åâäÉ éêÉëJ ëìêÉ ï~ë ãÉ~ëìêÉÇ ~í íÜÉ éçëíÉêáçê íáÄá~ä ~êíÉêó ~åÇ Å~äÅìä~íáçå çÑ ~åâäÉLÄê~ÅÜá~ä áåÇÉñ E^_fF ï~ë éÉêÑçêãÉÇ ~ÅÅçêÇáåÖ íç p~åÅÜÉò Éí ~äK ENMFK ^ Ñáêëí Åçåíêçä Öêçìé EÅçåíêçäë fF áåÅäìÇÉÇ PMQ é~íáÉåíë ~ÇãáííÉÇ íç íÜÉ ë~ãÉ aÉé~êíãÉåí Ñçê çíÜÉê êÉ~ëçåë íÜ~å î~ëÅìä~ê ÇáëÉ~ëÉë ~åÇ ïÜç ïÉêÉ ÑêÉÉ çÑ ~êíÉêá~ä E`^aI m^aI çê ÅÉêÉÄêçî~ëÅìä~ê ÇáëÉ~ëÉF çê îÉåçìë íÜêçãÄÉãÄçäáÅ ÇáëÉ~ëÉ Easq ~åÇLçê éìäãçå~êó ÉãÄçäáëãFK qÜáë Öêçìé ï~ë ã~íÅÜÉÇ Ñçê ~ÖÉ ~åÇ ëÉñ íç íÜÉ é~íáÉåíë ÖêçìéK ^ ëÉÅçåÇ åçåJ ã~íÅÜÉÇ Åçåíêçä Öêçìé EÅçåíêçäë ffF çÑ ONQ ÜÉ~äíÜó ëìÄàÉÅíë ï~ë êÉÅêìáíJ ÉÇ ~ãçåÖ ëíìÇÉåíë ~åÇ ÉãéäçóÉÉë çÑ íÜÉ ë~ãÉ aÉé~êíãÉåíK sÉåçìë ÄäççÇ ï~ë ÅçääÉÅíÉÇ áå R ãä baq^ íìÄÉëI ÖÉåçãáÅ ak^ ï~ë áëçä~íÉÇ ìëáåÖ ~ kìÅäÉçëéáå _äççÇ âáí Ej~ÅÜÉêÉóJk~ÖÉäF ~åÇ ëíçêÉÇ ~í Qø `K ^å~äóëáë çÑ dm fff~ ÖÉåçíóéÉë ï~ë éÉêÑçêãÉÇ Äó ~ääÉäÉJëéÉÅáÑáÅ ÇáÖÉëJ íáçå çÑ éçäóãÉê~ëÉ ÅÜ~áå êÉ~Åíáçå éêçÇìÅíë ENNFK q~ÄäÉ N ëÜçïë Ä~ëÉäáåÉ Ç~í~ ~åÇ ÖÉåçíóéÉ ÇáëíêáÄìíáçå çÑ é~íáÉåíë ~åÇ ÅçåíêçäëK få ÄçíÜ Åçåíêçä ÖêçìéëI ÅçåîÉåíáçå~ä êáëâ Ñ~Åíçêë ïÉêÉ ëáÖåáÑáÅ~åíäó ãçêÉ ÑêÉèìÉåí íÜ~å ~ãçåÖ é~íáÉåíëK dmfff~ ÖÉåçíóéÉ ÇáëJ íêáÄìíáçå ~åÇ ~ääÉäÉ ÑêÉèìÉåÅáÉë ïÉêÉ åçí ëáÖåáÑáÅ~åíäó ÇáÑÑÉêÉåí ÄÉíïÉÉå é~íáÉåíë ~åÇ ÅçåíêçäëK lÇÇë ê~íáç çÑ Å~êêáÉêë çÑ íÜÉ mä^O ~ääÉäÉI ÇÉíÉêJ ãáåÉÇ ìëáåÖ Åçåíêçäë f ~åÇ ff ÅçãÄáåÉÇ ~ë êÉÑÉêÉåÅÉ Öêçìé ~åÇ ~ÇàìëíÉÇ Ñçê çíÜÉê êáëâ Ñ~ÅíçêëI ï~ë MKVN EVRB ÅçåÑáÇÉåÅÉ áåíÉêî~ä MKPQJOKQSX é Z MKUSFK qÜÉ dm fff~ ÖÉåçíóéÉ ï~ë åçí ~ëëçÅá~íÉÇ ïáíÜ ~ÖÉ ~í çåëÉí çÑ m^a Eé Z MKOQFI cçåí~áåÉ ëí~ÖÉ çÑ íÜÉ ÇáëÉ~ëÉ EMKSSFI ~åâäÉ éêÉëëìêÉ Eé Z MKTOFI çê ^_f Eé Z MKUPFK cêÉèìÉåÅáÉë çÑ dm fff~ ÖÉåçíóéÉë çÑ é~J íáÉåíë ~åÇ Åçåíêçäë çÑ çìê ëíìÇó ïÉêÉ ëáãáä~ê íç Ç~í~ êÉéçêíÉÇ Äó éêÉîáçìë ëíìÇáÉëI áåÇáÅ~íáåÖ ~ ê~íÜÉê ÉîÉå ÇáëíêáÄìíáçå çÑ íÜáë éçäóãçêJ éÜáëã ~ãçåÖ `~ìÅ~ëá~åëK ^ ã~àçê éçáåí ïÜÉå áåíÉêéêÉíáåÖ ~ëëçÅá~íáçå ëíìÇáÉë ïáíÜ åÉÖ~íáîÉ êÉëìäíë áë íÜÉ éçëëáÄáäáíó çÑ ~ íóéÉ ff ÉêêçêI ïÜáÅÜ áë ÄÉáåÖ ïêçåÖ áå ÅçåJ ÅäìÇáåÖ íÜ~í íÜÉêÉ áë åç ~ëëçÅá~íáçåK rëáåÖ ~ ëáÖåáÑáÅ~åÅÉ äÉîÉä çÑ MKMRI ~ íïçJëáÇÉÇ íÉëíI ~åÇ ~ëëìãáåÖ ~ Å~êêáÉê ÑêÉèìÉåÅó çÑ ORB ~ãçåÖ ÅçåJ íêçäëI çìê ëíìÇó Ü~Ç ~ ëí~íáëíáÅ~ä éçïÉê çÑ MKVN íç ÇÉíÉÅí ~ êÉä~íáîÉ êáëâ çÑ NKR Ñçê Å~êêáÉêë çÑ íÜÉ mä^O ~ääÉäÉK få ÅçåÅäìëáçåI çìê Ç~í~ ëìÖÖÉëí íÜ~í íÜÉ mä^NL^O éçäóãçêéÜáëã çÑ íÜÉ dm fff~ ÖÉåÉ áë åçí ~ëëçÅá~íÉÇ ïáíÜ m^aK ^å~äóëáë çÑ íÜáë ã~êâÉê áë åçí ìëÉÑìä íç áÇÉåíáÑó ëìÄàÉÅíë ïÜç ~êÉ ~í ÜáÖÜÉê êáëâ Ñçê íÜáë ÇáëÉ~ëÉK cìêíÜÉê ëíìÇáÉë ~êÉ êÉèìáêÉÇ íç áåîÉëíáÖ~íÉ íÜÉ ÑìåÅíáçå~ä ÅçåëÉèìÉåÅÉë çÑ íÜáë éçäóãçêéÜáëã áå îáîçK

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.

OBJECTIVE We designed this prospective study to test the hypothesis that platelet antigen (PlA) polymorphism of glycoprotein (GP) IIIa is associated with an increased risk for adverse events after coronary stent placement. BACKGROUND Platelets play a central role in arterial thrombosis. The PlA polymorphism of GP IIIa, a constituent of the fibrinogen receptor, may influence the platelet funct...

متن کامل

Effect of PlA1/A2 glycoprotein IIIa gene polymorphism on the long-term outcome after successful coronary stenting

AIM To prospectively determine the role of platelet glycoprotein IIIa (GP IIIa) gene PlA1/PlA2 polymorphism on the long-term clinical outcome in patients with coronary artery disease undergoing coronary stenting. DESIGN AND SETTING Prospective observational study in the University Hospital of Caen (France). PATIENTS AND METHODS 1 111 symptomatic consecutive Caucasian patients treated with p...

متن کامل

PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.

OBJECTIVE To investigate potential associations of the PlA1/A2 polymorphism of the platelet glycoprotein IIIa (GPIIIa) gene with susceptibility to, and clinical expression of, giant cell arteritis (GCA). METHODS One hundred forty patients with biopsy-proven GCA who were residents of Reggio Emilia, Italy, and 241 population-based healthy controls from the same geographic area were genotyped fo...

متن کامل

The effects of platelet receptor GPIIb/IIIa polymorphism (Leu Pro33) on the receptor expression and platelet aggregation in patients with ischaemic stroke.

Platelet hyperaggregation in ischaemic stroke patients is a proven finding, and associated with increased expression of the platelet surface GPIIb/IIIa receptor. The polymorphism occurs at nucleotide position 1565 of the GPIIIa gene resulting a 33Leu-Pro change. Data are conflicting regarding the abnormal function of the PlA1/A2 receptor in stroke. The aim of the study was to address the differ...

متن کامل

PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement.

BACKGROUND Platelets play a central role in the process of restenosis after percutaneous coronary interventions. A polymorphism of platelet glycoprotein IIIa (PlA) has been associated with a higher risk of coronary thrombosis. We designed this prospective study to test the hypothesis that PlA polymorphism of glycoprotein IIIa is associated with an increased risk for restenosis after coronary st...

متن کامل

Common rs5918 (PlA1/A2) polymorphism in the ITGB3 gene and risk of coronary artery disease

INTRODUCTION The T to C transition at nucleotide 1565 of the human glycoprotein IIIa (ITGB3) gene represents a genetic polymorphism (PlA1/A2) that can influence both platelet activation and aggregation and that has been associated with many types of disease. Here, we present a newly designed multiplex tetra-primer amplification refractory mutation system - polymerase chain reaction (T-ARMS-PCR)...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Thrombosis and haemostasis

دوره 85 4  شماره 

صفحات  -

تاریخ انتشار 2001